These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26546635)

  • 1. Short- and Long-term Biologic Variability of Galectin-3 and Other Cardiac Biomarkers in Patients with Stable Heart Failure and Healthy Adults.
    Schindler EI; Szymanski JJ; Hock KG; Geltman EM; Scott MG
    Clin Chem; 2016 Feb; 62(2):360-6. PubMed ID: 26546635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of serum levels of high sensitivity troponin T, galectin-3 and C-terminal propeptide of type I procollagen at long term follow-up in heart failure patients with reduced ejection fraction: Comparison with soluble AXL and BNP.
    Batlle M; Campos B; Farrero M; Cardona M; González B; Castel MA; Ortiz J; Roig E; Pulgarín MJ; Ramírez J; Bedini JL; Sabaté M; García de Frutos P; Pérez-Villa F
    Int J Cardiol; 2016 Dec; 225():113-119. PubMed ID: 27718443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Biomarkers to Predict Readmission for Congestive Heart Failure.
    Sudharshan S; Novak E; Hock K; Scott MG; Geltman EM
    Am J Cardiol; 2017 Feb; 119(3):445-451. PubMed ID: 27939586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined determination of B-type natriuretic peptide and high-sensitivity troponin I in the postmortem diagnosis of cardiac disease.
    Bañón R; Hernández-Romero D; Navarro E; Pérez-Cárceles MD; Noguera-Velasco JA; Osuna E
    Forensic Sci Med Pathol; 2019 Dec; 15(4):528-535. PubMed ID: 31471870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure.
    Wang CH; Cheng ML; Liu MH; Kuo LT; Shiao MS
    J Cardiol; 2017 Jul; 70(1):92-98. PubMed ID: 28318874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in discharged chronic heart failure patients.
    Feola M; Testa M; Leto L; Cardone M; Sola M; Rosso GL
    Medicine (Baltimore); 2016 Jun; 95(26):e4014. PubMed ID: 27368017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure.
    Ralli S; Horwich TB; Fonarow GC
    Am Heart J; 2005 Dec; 150(6):1220-7. PubMed ID: 16338262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia.
    Puelacher C; Wagener M; Honegger U; Assadian M; Schaerli N; Mueller D; Strebel I; Twerenbold R; Boeddinghaus J; Nestelberger T; Wildi K; Sabti Z; Sazgary L; Badertscher P; du Fay de Lavallaz J; Marbot S; Kaiser C; Wild D; Zellweger MJ; Reichlin T; Mueller C
    Clin Biochem; 2018 Feb; 52():33-40. PubMed ID: 29107010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of biomarkers in patients with chronic heart failure and healthy controls.
    Meijers WC; van der Velde AR; Muller Kobold AC; Dijck-Brouwer J; Wu AH; Jaffe A; de Boer RA
    Eur J Heart Fail; 2017 Mar; 19(3):357-365. PubMed ID: 27766733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker-based risk prediction in the community.
    AbouEzzeddine OF; McKie PM; Scott CG; Rodeheffer RJ; Chen HH; Michael Felker G; Jaffe AS; Burnett JC; Redfield MM
    Eur J Heart Fail; 2016 Nov; 18(11):1342-1350. PubMed ID: 27813304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reference values of galectin-3 and cardiac troponins derived from a single cohort of healthy blood donors.
    Mueller T; Egger M; Leitner I; Gabriel C; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2016 May; 456():19-23. PubMed ID: 26920637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.
    Mueller T; Gegenhuber A; Leitner I; Poelz W; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2016 Dec; 463():158-164. PubMed ID: 27983996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.
    Ho JE; Liu C; Lyass A; Courchesne P; Pencina MJ; Vasan RS; Larson MG; Levy D
    J Am Coll Cardiol; 2012 Oct; 60(14):1249-56. PubMed ID: 22939561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of heart failure risk prediction models based on a multi-marker approach using random forest algorithms.
    Yuan H; Fan XS; Jin Y; He JX; Gui Y; Song LY; Song Y; Sun Q; Chen W
    Chin Med J (Engl); 2019 Apr; 132(7):819-826. PubMed ID: 30829708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant Recipients.
    Jarolim P; Claggett BL; Conrad MJ; Carpenter MA; Ivanova A; Bostom AG; Kusek JW; Hunsicker LG; Jacques PF; Gravens-Mueller L; Finn P; Solomon SD; Weiner DE; Levey AS; Pfeffer MA
    Transplantation; 2017 Jan; 101(1):182-190. PubMed ID: 26910333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
    Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M
    Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure.
    Wang CH; Yang NI; Liu MH; Hsu KH; Kuo LT
    Cardiol J; 2016; 23(5):563-572. PubMed ID: 27515479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing the upper reference limit of Galectin-3 in healthy blood donors.
    Agnello L; Bellia C; Lo Sasso B; Pivetti A; Muratore M; Scazzone C; Bivona G; Lippi G; Ciaccio M
    Biochem Med (Zagreb); 2017 Oct; 27(3):030709. PubMed ID: 29180917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional value of Galectin-3 to BNP in acute heart failure patients with preserved ejection fraction.
    Beltrami M; Ruocco G; Dastidar AG; Franci B; Lucani B; Aloia E; Nuti R; Palazzuoli A
    Clin Chim Acta; 2016 Jun; 457():99-105. PubMed ID: 27067445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.